From October 13rd to 15th, the second International Conference for Cancer Metabolism and Therapy (ICMT) was successfully held by the First Affiliated Hospital of Wenzhou Medical University in Wenzhou Awailou Resort. 280 national and international experts on oncology and related specialists attended the conference and had a vigorous discussion on Cancer Metabolism and Therapy.
The conference was presided over by Prof. Gary G Xiao, Adjunct Professor of UCLA Center for Excellence in Pancreatic Diseases. Prof. Shengwei Jin, Vice-president of Wenzhou Medical University and Prof Mengtao Zhou, President of the First Hospital of Wenzhou Medical University delivered opening speeches to extend their welcome to all the guests and colleagues. During the conference, around 20 scholars including Prof. Vay Liang W(Bill) Go, Distinguished Professor and Director of UCLA Center for Excellence in Pancreatic Diseases, Preof. Wai-nang Paul Lee, Director of Biomedical Mass Spectrometry Laboratory of UCLA, Prof. Andrea Cossarizza, Director of School of Specialization in Clinical Pathology, University of Modena and Reggio Emilia School of Medicine Department of Medical and Surgical Sciences for Children and Adults and Prof. Laszlo G Boros, professor of the Department of Pediatrics, University of California, gave their latest progress reports on Cancer Metabolism, drug resistance and individual therapy.
In 2011, altered metabolism was listed as one of the ten most important features of tumor cells by Cell Journal, which started a new trend on Tumor Metabolism Research. It has been confirmed to date the interaction between cell metabolism and Tumor as both cause and effect. However, there are still a number of crucial issues in this field that needs further discussion by joint efforts, which is also the goal for organizing this conference.
As the burden of cancer is increasing rampantly and posing challenges in early diagnosis and treatment, this conference is planned to hold every other year with the aim of identifying the genuine need in the area and its implementation for patient welfare. The conference covered a wide range of topics in cancer such as etiology, epidemiology, metabolic reprogramming, environment altered cellular metabolism, cancer prevention and vaccine, new drug development, multidisciplinary treatment i.e. surgical therapy, chemotherapy, and radiotherapy and cancer stem cell therapy. The success of this conference paved the way for cancer therapy and research to step into a new era of rapid and significant developments not only in the West but also in Asia as well.